What This FDA Delay Means for Novartis

What This FDA Delay Means for Novartis

Submitted by admin on July 21, 2022 - 10:36am
Source: 
Motley Fool
News Tags: 
Novartis
FDA
cancer
tislelizumab
Headline: 
What This FDA Delay Means for Novartis
snippet: 
  • Novartis hopes to launch a cancer drug to compete with Keytruda and Opdivo.
  • However, the FDA has delayed a ruling on the Novartis candidate amid COVID-19 challenges.
  • The agency was unable to inspect Chinese manufacturing sites due to travel restrictions.

Do Not Allow Advertisers to Use My Personal information